Skip to content

Bronchoalveolar Immune Response Determination

Study to Determine the Immune Response From Broncho-alveolar Cells Against Pigeon Specific Antigens

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01237145
Acronym
BIRD
Enrollment
10
Registered
2010-11-09
Start date
2011-09-30
Completion date
2012-12-31
Last updated
2018-01-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Extrinsic Allergic Alveolitis

Keywords

pigeon, bird fancier, extrinsic allergic alveolitis, BAL, broncho-alveolar lavage, elispot, antigen

Brief summary

The purpose of this study is to establish if cells present in lung tissue during extrinsic allergic alveolitis (EAA) are able to elicit an immune response against specific antigens. The hypothesis is: cells in BAL lavage fluid from patients with EAA will be responsive to specific antigens and this response can be measured using ELISPOT.

Detailed description

Subjects suffering from extrinsic allergic alveolitis caused by pigeons will undergo a broncho alveolar lavage. Cells obtained from this BAL will be used for ELISPOT technique with pigeon specific antigens

Interventions

None listed

Sponsors

Bossink, A.W.J.
Lead SponsorINDIV

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* suspicion of pigeon induced extrinsic alveolitis

Exclusion criteria

* use of oral steroids * unable to give informed consent * age below 18

Design outcomes

Primary

MeasureTime frameDescription
ELISPOT response in cells obtained from broncho-alveolar lavage2 daysAll elispots will be performed the same day, the end point will be available the next day

Secondary

MeasureTime frameDescription
Elispot response in cells from blood2 daysELispots will be performed the same day as blood collection, results will be available the next day

Countries

Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026